These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8151008)

  • 21. Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.
    Di Bella D; Erzegovesi S; Cavallini MC; Bellodi L
    Pharmacogenomics J; 2002; 2(3):176-81. PubMed ID: 12082589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral side effects in obsessive-compulsive patients treated with fluvoxamine: a clinical description.
    Diaferia G; Mundo E; Bianchi Y; Ronchi P
    J Clin Psychopharmacol; 1994 Feb; 14(1):78-9. PubMed ID: 8151009
    [No Abstract]   [Full Text] [Related]  

  • 23. Body dysmorphic disorder and obsessive-compulsive disorder: similarities, differences and the classification debate.
    Chosak A; Marques L; Greenberg JL; Jenike E; Dougherty DD; Wilhelm S
    Expert Rev Neurother; 2008 Aug; 8(8):1209-18. PubMed ID: 18671665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluvoxamine induced oculogyric dystonia and manic switch in a patient with obsessive compulsive disorder.
    Tikka SK; Garg S; Das B
    Indian J Pharmacol; 2013; 45(5):532-3. PubMed ID: 24130396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dystonic reaction associated with fluvoxamine.
    George MS; Trimble MR
    J Clin Psychopharmacol; 1993 Jun; 13(3):220-1. PubMed ID: 8354740
    [No Abstract]   [Full Text] [Related]  

  • 27. Compulsive personality as predictor of response to serotoninergic antidepressants.
    Ansseau M; Troisfontaines B; Papart P; von Frenckell R
    BMJ; 1991 Sep; 303(6805):760-1. PubMed ID: 1932937
    [No Abstract]   [Full Text] [Related]  

  • 28. Serotonin syndrome from fluvoxamine and buspirone.
    Baetz M; Malcolm D
    Can J Psychiatry; 1995 Sep; 40(7):428-9. PubMed ID: 8548727
    [No Abstract]   [Full Text] [Related]  

  • 29. Obsessive-compulsive disorder and its treatment with serotonin-selective agents.
    Murphy DL; Pigott TA
    Prog Clin Biol Res; 1990; 361():179-201. PubMed ID: 2290841
    [No Abstract]   [Full Text] [Related]  

  • 30. [Disorders of body perception in schizophrenic psychosis. A case report].
    Schmoll D; Koch T
    Nervenarzt; 1989 Oct; 60(10):619-27. PubMed ID: 2586687
    [No Abstract]   [Full Text] [Related]  

  • 31. Obsessive-compulsive disorder in relation to body dysmorphic disorder.
    Tanquary J; Lynch M; Masand P
    Am J Psychiatry; 1992 Sep; 149(9):1283-4. PubMed ID: 1482445
    [No Abstract]   [Full Text] [Related]  

  • 32. Body dysmorphic disorder.
    Albertini RS; Phillips KA; Guevremont D
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1425-6. PubMed ID: 8936908
    [No Abstract]   [Full Text] [Related]  

  • 33. Seizures induced by combined levomepromazine-fluvoxamine treatment.
    Grinshpoon A; Berg Y; Mozes T; Mester R; Weizman A
    Int Clin Psychopharmacol; 1993; 8(1):61-2. PubMed ID: 8473723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interactive metabolism effect of oxcarbazepine coadministered with tricyclic antidepressant therapy for OCD symptoms.
    Baird P
    J Clin Psychopharmacol; 2003 Aug; 23(4):419-20. PubMed ID: 12920423
    [No Abstract]   [Full Text] [Related]  

  • 35. Bowel obsessions responsive to tricyclic antidepressants in four patients.
    Jenike MA; Vitagliano HL; Rabinowitz J; Goff DC; Baer L
    Am J Psychiatry; 1987 Oct; 144(10):1347-8. PubMed ID: 3661771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hair loss associated with fluvoxamine use.
    Parameshwar E
    Am J Psychiatry; 1996 Apr; 153(4):581-2. PubMed ID: 8599419
    [No Abstract]   [Full Text] [Related]  

  • 37. [The obsessive-compulsive disorder. Pharmacotherapeutic and neurobiological aspects and the relation to affective pathology].
    Fornaro P
    Minerva Psichiatr; 1988; 29(2):95-103. PubMed ID: 3057306
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute exacerbation of body dysmorphic disorder during tryptophan depletion.
    Barr LC; Goodman WK; Price LH
    Am J Psychiatry; 1992 Oct; 149(10):1406-7. PubMed ID: 1388335
    [No Abstract]   [Full Text] [Related]  

  • 39. Urge to splurge.
    Black DW; Gabel J; Schlosser S
    Am J Psychiatry; 1997 Nov; 154(11):1629-30. PubMed ID: 9356587
    [No Abstract]   [Full Text] [Related]  

  • 40. Body-dysmorphic disorder.
    Thomas CS
    Am J Psychiatry; 1990 Jun; 147(6):816-7. PubMed ID: 2343936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.